Health and Medical News LONDON (Reuters) - AstraZeneca's board was meeting on Friday morning to consider an improved $106 billion takeover offer from U.S. drugmaker Pfizer, two people familiar with the matter said. An AstraZeneca spokeswoman confirmed the company'...
by via @ Health and Medical News
by via @ Health and Medical News